Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADOPT: Oral vs. Injectable Naltrexone for Alcohol Use Disorder
NCT02478489Phase 4Completed
- Sponsor
- Boston University
- Start
- Jun 2016
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in alcohol use disorder (AUD), sponsored by Boston University. Started Jun 2016; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02478489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478489.